Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - SHORT-TERM INVESTMENTS
Short-term Investments NBIX - Neurocrine Biosciences, Inc.
843 M
LAST VALUE
7.73%
2 YEAR CAGR
8.60%
5 YEAR CAGR
17.88%
10 YEAR CAGR